Product claims are attributed to the brand and are not independently endorsed
Additinally, I didnt plan to watch a video learning about the incredible array of benefits from GHK-Cu, but the YT vid you posted with Dr Quinn Stillson, breaking down the physiology, current levels of research, efficacy, risks and benefits of topical vs sub -cu, was simply phenomenal
More research needed Berry and Iqbal said the findings were promising, but tirzepatide still needs to be assessed in fully powered randomized controlled trials enrolling adults with type 1 diabetes
Hims in March announced it would partner with Novo Nordisk for its branded drugs but would continue to sell compounded versions in special doses or formulations, as regulations allow
Cold Spring Harbor Perspectives in Biology, 10 (4), Article a022293